Cannabis Reform Foes Cite GAO in Push to Reopen Hearings
Opponents of cannabis reform pointed to a GAO document to argue for reopening hearings, Law360 reported, though the filing's forum and contents remain unconfirmed.
From above of wooden gavel on round surface near folders on table in courtroom
What Law360 reported
Law360 reported Oct. 15 that opponents of cannabis reform cited the Government Accountability Office in urging that hearings be reopened. That's the full confirmed record.
The headline names no filer, forum, or GAO product. CannIntel worked from the headline and metadata only and hasn't reviewed the underlying document.
Which hearings? Two readings
"Reopen hearings" could describe either a DEA administrative proceeding or a congressional hearing, and the stakes differ sharply. The signal doesn't say which.
Under 21 U.S.C. § 811(a), rescheduling by rule requires a record made after opportunity for a hearing under 5 U.S.C. § 553 rulemaking procedures. A request to reopen that record would be a procedural filing with real timing consequences. A congressional hearing request is a political lever with no binding effect on DEA.
The rescheduling docket in brief
DEA's marijuana rulemaking began with a May 21, 2024 NPRM, published at 89 Fed. Reg. 44597, proposing a move from Schedule I to Schedule III. Schedule I status is set by 21 U.S.C. § 812(c).
Schedule III placement would take state-licensed operators out of Internal Revenue Code § 280E. That's the financial reason every procedural fight over this docket draws operator attention.
Why a GAO citation matters
GAO is Congress's nonpartisan auditor, so citing it puts a government-authored finding in front of decision-makers without leaning on advocacy groups. Smart choice of authority.
The headline establishes who is asking and what they cite. It doesn't establish which GAO product is at issue or what it says, and that gap decides whether the filing has teeth.
What operators and investors should watch
The filing's forum and requested relief will determine whether this is noise or a delay risk. For full background, see the CannIntel topic hub on DEA marijuana rescheduling.
- Who filed, and in which docket or committee
- Whether the request seeks to supplement the record or halt proceedings
- Any DEA or Department of Justice response
What remains unconfirmed
Nothing in the available signal shows a hearing has been granted, scheduled, or denied. Not yet.
A request to reopen isn't a ruling. Agencies deny such requests routinely, though a granted one can add months to a docket that operators in California, Ohio, and other state markets have already priced into their 2027 tax planning.
Next up: the underlying filing text and any docket entry in response. We'll update when either surfaces.
For complete background, history, and our ongoing coverage of this story:
Open the CannIntel topic hub →Frequently asked questions
Who is pushing to reopen the hearings?
Law360's headline describes them only as cannabis reform foes. The available signal doesn't name the filers, the forum, or the specific GAO document cited, so CannIntel is not attributing the effort to any named party.
Does this change marijuana's Schedule I status?
No. Marijuana remains in Schedule I under 21 U.S.C. § 812(c) unless a final rule changes it. A request to reopen hearings is not a ruling, and nothing in the signal shows one has been granted.
Why would a hearing request matter to operators?
Moving marijuana to Schedule III would end Section 280E's application to state-licensed operators. Any procedural step that extends the rulemaking record could delay that tax relief.
What is the GAO?
The Government Accountability Office is Congress's nonpartisan audit and oversight agency. Its reports are often cited in policy fights because they are government-authored rather than advocacy documents.
Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Laws
South Dakota AG Says Medical Marijuana Law Meets Rescheduling
A South Dakota attorney general's legal opinion concludes the state's existing medical marijuana laws need no changes to comply with federal rescheduling, a position other states may adopt.
DEA Judge Orders New Replies as Marijuana Rescheduling Stays Stalled
A DEA administrative law judge ordered fresh replies in the Schedule III proceeding, which remains sidelined with no final rule in sight.
Vermont Event Permits Could Open Legal Cannabis Sales at Fairs
WCAX reports a Vermont event-permit concept could extend legal cannabis sales past licensed storefronts to community events, though the rules remain unpublished in the available report.
More from the newsroom
Nebraska MMJ Growers Harvest First Crops With No Buyers Yet
Nebraska's first medical cannabis harvests are coming in before any processor, transporter, lab or dispensary exists to take delivery, MJBizDaily reported.
South Dakota AG Says Medical Marijuana Law Already Meets Rescheduling
A South Dakota attorney general opinion says existing medical marijuana rules need no changes after federal rescheduling, a template other state regulators may copy.
Boston Mayor Joins Effort to Protect Massachusetts Legal Cannabis
Boston's mayor backed an effort to protect Massachusetts' adult-use market on Oct. 14, putting the state's largest city behind the campaign.